Caligan Partners »

Maze Therapeatics shares owned by Caligan Partners

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Caligan Partners from 13F filings

Historical chart of Caligan Partners investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Caligan Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Caligan Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $23M 550k 41.43

More positions owned by Caligan Partners

Liquidia Corporation Com New (LQDA)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Exelixis (EXEL)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Inhibrx Biosciences (INBX)
Tango Therapeutics (TNGX)
Tyra Biosciences (TYRA)
Maze Therapeatics (MAZE)
Rapt Therapeutics Com New (RAPT)
Avalo Therapeutics Com New (AVTX)
Anika Therapeutics (ANIK)

View all positions for Caligan Partners

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Arch Venture Corp
Deep Track Capital
Alphabet
AH Capital Management
Vanguard Group
VR Adviser
BlackRock
General Catalyst Group Management
Woodline Partners
TRV GP V
Logos Global Management
Marshall Wace
Casdin Capital

View all funds holding Maze Therapeatics